Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Amphora Discovery Announces Inflammatory Disease Collaboration

By Pharmaceutical Processing | January 20, 2005

Amphora Discovery Corporation recently announced it has entered into a multi-year research partnership with Ortho-McNeil Pharmaceutical, Inc. to discover and develop new treatments for inflammatory disease; an important therapeutic area that includes cardiovascular disease, rheumatoid arthritis, asthma, diabetes, inflammatory bowel disease and multiple sclerosis.

Under terms of the agreement, Ortho-McNeil will license several lead series of compounds identified by Amphora that are focused on a widely recognized inflammation target for which a successful therapy has not yet been identified. Amphora will grant Ortho-McNeil exclusive rights to the existing compounds as well as new compounds discovered during the collaboration, and Ortho-McNeil’s affiliate Johnson & Johnson Pharmaceutical Research & Development, L.L.C., will further develop the licensed compounds and provide research support to Amphora. Financial terms of the agreement were not disclosed, but include research support payments, an up-front licensing fee and the possibility of milestone payments and royalties for compounds developed under the collaboration.

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE